Prevalence and correlates of anemia in a large cohort of HIV-infected women: Women's Interagency HIV Study
Article Abstract:
Many HIV-infected women may develop anemia, according to a study of 2,056 HIV-infected women and 569 non-infected women. Thirty-seven percent of the HIV-infected women were anemic, compared to 17% of the HIV-negative women. Low CD4 T cell counts, high viral counts, and use of zidovudine were risk factors for anemia.
Publication Name: Journal of Acquired Immune Deficiency Syndromes (1999)
Subject: Health
ISSN: 1525-4135
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
Impact of highly active antiretroviral therapy on anemia and relationship between anemia and survival in a large cohort of HIV-infected women: women's interagency HIV study.
Article Abstract:
The study was conducted to ascertain the impact of highly active antiretroviral therapy (HAART) on anemia and the relationship between anemia and overall survival in HIV-infected women. It was found that anemia is an independent risk factor for decreased survival among HIV-infected women and HAART therapy for as little as six months is associated with resolution of anemia.
Publication Name: Journal of Acquired Immune Deficiency Syndromes (1999)
Subject: Health
ISSN: 1525-4135
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
Factors and temporal trends associated with highly active antiretroviral therapy discontinuation in the women's interagency HIV study
Article Abstract:
The factors and temporal trends associated with discontinuation of highly active antiretroviral therapy (HAART) among 936 HIV-infected women enrolled in the Women's Interagency HIV Study are characterized. A multivariate analysis of post-HAART initiation exposures found that high HIV RNA levels and high depressive symptom scores were associated with HAART discontinuation.
Publication Name: Journal of Acquired Immune Deficiency Syndromes (1999)
Subject: Health
ISSN: 1525-4135
Year: 2005
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Prevalence and predictors of highly active antiretroviral therapy use in patients with HIV infection in the United States
- Abstracts: Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection
- Abstracts: Once-daily regimen of saquinavir, ritonavir, didanosine, and lamivudine in HIV-infected patients with standard tuberculosis therapy (TBQD Study)
- Abstracts: Comparison of T-cell subsets' reconstitution after 12 months of highly active antiretroviral therapy initiated durign early versus advanced states fo HIV disease
- Abstracts: Mode of delivery and postpartum morbidity among HIV-infected women: the Women and Infants Transmission Study. Multicenter review of protease inhibitors in 89 pregnancies